Aminoglycosides: Perspectives on mechanisms of action and resistance and strategies to counter resistance

Antimicrobial Agents and Chemotherapy

Volumn 44, Issue 12, 2000, Pages 3249-3256

  Kotra, L P ^a   Haddad, J ^a   Mobashery, S ^a  

^a WAYNE STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT;

DRUG ACTIVITY; DRUG BINDING; DRUG MECHANISM; DRUG RESISTANCE; DRUG STRUCTURE; PRIORITY JOURNAL; SHORT SURVEY;

AMINOGLYCOSIDES; ANTI-BACTERIAL AGENTS; BACTERIA; CARBOHYDRATE SEQUENCE; DRUG DESIGN; DRUG RESISTANCE, MICROBIAL; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; RNA, RIBOSOMAL, 16S; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0034426097     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.44.12.3249-3256.2000     Document Type: Short Survey

References (57)

1. Probing the specificity of aminoglycoside-ribosomal RNA interactions with designed synthetic analogs
2. Properties of a bifunctional bacterial antibiotic resistance enzyme that catalyzes ATP-dependent 2″-phosphorylation and acetyl-CoA-dependent 6′-acetylation of aminoglycosides
3. Sites of action of two ribosomal RNA methylases responsible for resistance to aminoglycosides
4. Aminoglycoside-induced hearing loss in humans
5. X-ray crystal structure of 70S ribosome functional complexes
6. Self-splicing of group I introns
7. The binding site of a specific aminoglycoside binding RNA molecule
8. Specificity in the binding of aminoglycosides to HIV-RRE RNA
9. Prodigious substrate specificity of AAC(6′)-APH(2″), an aminoglycoside antibiotic resistance determinant in enterococci and staphylococci
10. Mechanism of bactericidal action of aminoglycosides
11. Bacterial pathogens isolated from patients with skin and soft tissue infections: Frequency of occurrence and antimicrobial susceptibility patterns from the SENTRY Antimicrobial Surveillance Program (United States and Canada, 1997)
12. Structure of the A-site of Escherichia coli 16S ribosomal RNA complexed with an aminoglycoside antibiotic
13. Binding of neomycin-class aminoglycoside antibiotics to the A-site of 16 S rRNA
14. Paromomycin binding induces a local conformational change in the A-site of 16 S rRNA
15. Design and synthesis of new aminoglycoside antibiotics containing neamine as an optimal core structure: Correlation of antibiotic activity with in vitro inhibition of translation
16. An antibiotic clocked by its own resistance enzyme
17. Hydroxyamines as a new motif for the molecular recognition of phosphodiesters: Implications for aminoglycoside-RNA interactions
18. Direct observation of aminoglycoside-RNA interactions by surface plasmon resonance
19. Saccharide-RNA recognition
20. Docking of cationic antibiotics to negatively charged pockets in RNA folds
21. Structure of an enzyme required for aminoglycoside antibiotic resistance reveals homology to eukaryotic protein kinases
22. Novel mutation in 16S rRNA associated with streptomycin dependence in Mycobacterium tuberculosis
23. Solution structure of the tobramycin-RNA aptamer complex
24. Mutations in ribosomal protein L10e confer resistance to the fungal specific eukaryotic elongation factor 2 inhibitor sordarin
25. Alterations in the microbial flora and in the incidence of bacteremia at a university hospital after adoption of amikacin as the sole formulary aminoglycoside
26. Phe binds aminoglycoside antibiotics
27. Gentamicin, tobramycin, amikacin, sisomicin and netilmicin
28. RNA-aminoglycoside antibiotic interactions: Fluorescence detection of binding and conformational change
29. Recognition of aminoglycoside antibiotics by the enterococcal/staphylococcal aminoglycoside 3′-phosphotransferase type IIIa: Role of substrate amino groups
30. Enhanced RNA binding of dimerized aminoglycosides
31. Aminoglycosides: Nephrotoxicity
32. Aminoglycosides: Activity and resistance
33. Interaction of antibiotics with functional sites in 16S ribosomal RNA
34. Mechanisms of bacterial antibiotic resistance
35. Ribosomal RNA and translation
36. Structural investigation of the antibiotic and ATP-binding sites in kanamycin nucleotidyl transferases
37. Selective perturbation of G530 of 16S rRNA by translational miscoding agents and a streptomycin-dependence mutation in protein S12
38. Basis for prokaryotic specificity of action of aminoglycoside antibiotics
39. RNA sequence determinants for aminoglycoside binding to an A-site rRNA model oligonucleotide
40. Mechanism-based inactivation of bacterial aminoglycoside 3′-phosphotransferases
41. Inhibition of the self-cleavage reaction of the human hepatitis delta virus ribozyme by antibiotics
42. Molecular structure of kanamycin nucleotidyl transferase determined to 3 Å resolution
43. Prevalence of aminoglycoside resistance in 20 European university hospitals participating in the European SENTRY Antimicrobial Surveillance Programme
44. Molecular genetics of aminoglycoside resistant genes and familial relationships of the aminoglycoside-modifying enzymes
45. Inhibition of the hammerhead ribozyme by neomycin
46. Methylation of 16S ribosomal RNA and resistance to the aminoglycoside antibiotics gentamicin and kanamycin determined by DNA from the gentamicin-producer, Micromonospora purpurea
47. Simple aminols as aminoglycoside surrogates
48. Aminoglycoside hybrids as potent RNA antagonists
49. Deciphering RNA recognition: Aminoglycoside binding to the hammerhead ribozyme
50. The crystal structure of ribosomal protein L22 from Thermus thermophilus: Insights into the mechanism of erythromycin resistance
51. Footprinting the sites of interaction of antibiotics with catalytic group I intron RNA
52. Antibiotic inhibition of group I ribozyme function
53. Crystal structure of a GCN5-related N-acetyltransferase: Serratia marcescens aminoglycoside 3-N-acetyltransferase
54. A library approach to the discovery of small molecules that recognize RNA: Use of a 1,3-hydroxyamine motif as core
55. Aminoglycoside antibiotics: Structures, functions and resistance
56. Crystal structure of an aminoglycoside 6′-N-acetyltransferase: Defining the GCN5-related N-acetyltransferase superfamily fold
57. Structural origins of gentamicin antibiotic action